New Approaches to Drug Development, Jolles

Автор: Binghe Wang
Название: Drug-Drug Interactions in Pharmaceutical Development
ISBN: 0471794414 ISBN-13(EAN): 9780471794417
Издательство: Wiley
Рейтинг:
Цена: 106600.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market.

Автор: Tamaki
Название: Molecular Imaging for Integrated Medical Therapy and Drug Development
ISBN: 4431980733 ISBN-13(EAN): 9784431980735
Издательство: Springer
Рейтинг:
Цена: 213360.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Covers the proceedings of `Symposium for future drug discovery and medical care` that intends to exchange ideas how to promote molecular imaging technology and also how to extend the technology to medical therapy and drug development.

Автор: Joerg Bluemel
Название: The Nonhuman Primate in Nonclinical Drug Development and Safety A
ISBN: 0124171443 ISBN-13(EAN): 9780124171442
Издательство: Elsevier Science
Рейтинг:
Цена: 140360.00 T
Наличие на складе: Невозможна поставка.
Описание: The Nonhuman Primate in Drug Development and Safety Assessment is a valuable reference dedicated to compiling the latest research on nonhuman primate models in nonclinical safety assessment, regulatory toxicity testing and translational science. By covering important topics such as study planning and conduct, inter-species genetic drift, pathophysiology, animal welfare legislation, safety assessment of biologics and small molecules, immunotoxicology and much more, this book provides scientific and technical insights to help you safely and successfully use nonhuman primates in pharmaceutical toxicity testing. A comprehensive yet practical guide, this book is intended for new researchers or practicing toxicologists, toxicologic pathologists and pharmaceutical scientists working with nonhuman primates, as well as graduate students preparing for careers in this area.

Автор: Krishna, Rajesh
Название: Biopharmaceutics applications in drug development
ISBN: 1441944346 ISBN-13(EAN): 9781441944344
Издательство: Springer
Рейтинг:
Цена: 204040.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: The highly experienced authors here present readers with step-wise, detail-conscious information to develop quality pharmaceuticals. It provides a specific focus on the integration of regulatory considerations and includes case histories highlighting the biopharmaceutics strategies adopted in development of successful drugs.

Автор: Tansey, Michael
Название: Intelligent Drug Development
ISBN: 0199974586 ISBN-13(EAN): 9780199974580
Издательство: Oxford Academ
Рейтинг:
Цена: 60190.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: A guide to making the drug-development process more efficient, by way of analyzing various steps in clinical research.

Автор: Teicher
Название: Anticancer Drug Development Guide. 2ed.2004
ISBN: 1588292282 ISBN-13(EAN): 9781588292285
Издательство: Springer
Рейтинг:
Цена: 231990.00 T
Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel phase II clinical trial designs for targeted therapies have been significantly updated, along with those on cancer drug development in Europe, working with the NCI, and the FDA's role in cancer drug development and setting requirements for approval.